✦ LIBER ✦

Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: An 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial

✍ Scribed by Sang-Hyun Kim; Woo-Young Chung; Joo-Hee Zo; Myung-A Kim; Hyuk-Jae Chang; Young-Seok Cho; Tae-Jin Youn; In-Ho Chae; Dong-Joo Choi; Jae-Jin Gwak; Hae-Young Lee; Jin-Sik Park; Hyun-Jae Kang; Young-Jin Kim; Hyo-Soo Kim

Book ID: 113543991
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 146 KB
Volume: 31
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2009.05.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A twelve-week, multicenter, randomized,

A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: The Iberian Multicenter Imidapril study on hypertension (IMISH)

✍ Jose Luis Palma Gámiz; Mariano Pêgo; Emilio Márquez Contreras; Montserrat Pujol 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 878 KB

Comparison of efficacy and tolerability

Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up noninferiority trial

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Efficacy and safety profiles of a new S(

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

✍ Sung Ai Kim; Sungha Park; Namsik Chung; Do-Sun Lim; Joo-Young Yang; Byung-Hee Oh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Clinic blood pressure responses to two a

Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: A multicenter, randomized, double-blind, parallel-group, 8-week comparison

✍ Hae-Young Lee; Hyun-Jae Kang; Bon-Kwon Koo; Byung-Hee Oh; Kang Heung-Sun; Kee-Si 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 830 KB

Efficacy and Tolerability of a New Exten

Efficacy and Tolerability of a New Extended-Release Formulation of Nicotinic Acid in Korean Adults With Mixed Dyslipidemia: An 8-Week, Multicenter, Prospective, Randomized, Double-Blind, and Placebo-Controlled Trial

✍ Sang-Hyun Kim; Min-Kyung Kim; Hae-Young Lee; Hyun-Jae Kang; Yong-Jin Kim; Byung- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 523 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB